Table 3. Multivariate association between traditional CVD risk factors and cIMT among all participants and among HIV-infected participants.
All participants | HIV-infected participants | HIV-uninfected | ||||
---|---|---|---|---|---|---|
Predictor Variable | Estimate (95% CI) | P-value | Estimate (95% CI) | P-value | Estimate (95% CI) | P-value |
Age (per 5 year increase) | 0.030 (0.023, 0.037) | <0.001 | 0.018 (0.003–0.032) | 0.02 | 0.03579 (0.026–0.046) | <0.001 |
On treatment for hypertension | 0.026 (0.003–0.050) | 0.03 | 0.031 (-0.007–0.068) | 0.11 | ||
Non-HDL cholesterol | 0.012 (0.005, 0.019) | <0.001 | 0.012 (0.003–0.022) | 0.01 | ||
Waist-hip ratio | 0.260 (0.050–0.471) | 0.02 | ||||
HBA1C | 0.013 (0.0001–0.027) | 0.05 |
Abbreviations: HDL, high density lipoprotein; sCD163, soluble CD163; HBA1C, glycosylated haemoglobin
Greyed out areas indicate that these predictors were not significant in the final models